Document Detail


Ribosome-inactivating proteins: progress and problems.
MedLine Citation:
PMID:  16799768     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Ribosome-inactivating proteins (RIPs), mostly from plants, are enzymes which depurinate rRNA, thus inhibiting protein synthesis. They also depurinate other polynucleotide substrates. The biological activity of RIPs is not completely clarified, and sometimes independent of the inhibition of protein synthesis. There are differences in the cytotoxicity of RIPs and, consequently, in their toxicity to animals. Some RIPs are potent toxins, the best known being ricin, a potential biological weapon. New toxins have recently been identified. RIPs cause apoptotic and necrotic lesions, and induce production of cytokines causing inflammation. RIPs are potentially useful in agriculture and medicine because (i) they have antiviral activity and (ii) they are used for the preparation of conjugates with antibodies ('immunotoxins') or other carriers, rendering them specifically toxic to the cell target of the carrier, which may be helpful in therapy. The distribution, mechanism of action and role in nature of RIPs are not completely understood, and we can expect several future developments in their practical application.
Authors:
F Stirpe; M G Battelli
Related Documents :
20089798 - Variability in inhibition of host rna synthesis by entero- and cardioviruses.
9797308 - A small, dilute-cytoplasm, high-affinity, novel bacterium isolated by extinction cultur...
9582098 - Dbp7p, a putative atp-dependent rna helicase from saccharomyces cerevisiae, is required...
6363878 - Mitochondrial ribosomal rna genes of yeast: their mutations and a common nuclear suppre...
21192978 - Partial deletion in the spike endodomain of mouse hepatitis virus decreases the cytopat...
10809078 - Determination of proteins by fluorescence quenching of magdala red.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Cellular and molecular life sciences : CMLS     Volume:  63     ISSN:  1420-682X     ISO Abbreviation:  Cell. Mol. Life Sci.     Publication Date:  2006 Aug 
Date Detail:
Created Date:  2006-08-15     Completed Date:  2006-10-05     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9705402     Medline TA:  Cell Mol Life Sci     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  1850-66     Citation Subset:  IM    
Affiliation:
Dipartimento di Patologia sperimentale, Alma Mater Studiorum Università di Bologna, Via S. Giacomo 14, 40126, Bologna, Italy. fiorenzo.stirpe@unibo.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Antineoplastic Agents / therapeutic use
Humans
N-Glycosyl Hydrolases / metabolism*,  therapeutic use,  toxicity
Neurons / drug effects
Plant Proteins / metabolism*,  therapeutic use,  toxicity
RNA, Plant / genetics
RNA, Ribosomal / genetics
RNA, Ribosomal, 28S / genetics
Ribosomes / metabolism*
Chemical
Reg. No./Substance:
0/Antineoplastic Agents; 0/Plant Proteins; 0/RNA, Plant; 0/RNA, Ribosomal; 0/RNA, Ribosomal, 28S; EC 3.2.2.-/N-Glycosyl Hydrolases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Construction of a bacterial artificial chromosome library and characterization of hrp/hrc gene clust...
Next Document:  Phytanic acid: production from phytol, its breakdown and role in human disease.